Activation of epidermal growth factor receptor is required for Chlamydia trachomatis development

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Patel, Achchhe L ^a   Chen, Xiaofei ^a   Wood, Scott T ^a   Stuart, Elizabeth S ^b   Arcaro, Kathleen F ^b   Molina, Doris P ^a   Petrovic, Snezana ^a   Furdui, Cristina M ^a   Tsang, Allen W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; F ACTIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; STAT5 PROTEIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL INCLUSION; CELL LINE; CELL SURFACE; CHLAMYDIASIS; CONTROLLED STUDY; GENE SILENCING; HOST CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SURFACE PROPERTY; 3T3 CELL LINE; ANIMAL; BACTERIUM ADHERENCE; CHLAMYDIA TRACHOMATIS; GROWTH, DEVELOPMENT AND AGING; HELA CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; TRANSCRIPTION INITIATION;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS;

ANIMALS; BACTERIAL ADHESION; CHLAMYDIA TRACHOMATIS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 84924199277     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-014-0277-4     Document Type: Article

References (64)

1. Bakken IJ, Ghaderi S: Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis : a historical follow-up study. BMC Infect Dis 2009, 9:130.
2. Bender N, Herrmann B, Andersen B, Hocking JS, van Bergen J, Morgan J, van den Broek IV, Zwahlen M, Low N: Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Sex Transm Infect 2011, 87(7):601-608.
3. Rodgers AK, Budrys NM, Gong S, Wang J, Holden A, Schenken RS, Zhong G: Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility. Fertil Steril 2011, 96(3):715-721.
4. Hammond CJ, Hallock LR, Howanski RJ, Appelt DM, Little CS, Balin BJ: Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain. BMC Neurosci 2010, 11:121.
5. Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum-Hudson JA, Gerard HC, Hudson AP: Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis 2008, 13(4):371-380.
6. Gerard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH 2nd, Bordayo EZ, Whittum-Hudson JA, Hudson AP: Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol 2006, 48(3):355-366.
7. Byrne GI, Ojcius DM: Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2004, 2(10):802-808.
8. Miyairi I, Byrne GI: Chlamydia and programmed cell death. Curr Opin Microbiol 2006, 9(1):102-108.
9. Sharma M, Rudel T: Apoptosis resistance in Chlamydia-infected cells: a fate worse than death? FEMS Immunol Med Microbiol 2009, 55(2):154-161.
10. Ying S, Fischer SF, Pettengill M, Conte D, Paschen SA, Ojcius DM, Hacker G: Characterization of host cell death induced by Chlamydia trachomatis. Infect Immun 2006, 74(11):6057-6066.
11. Ying S, Pettengill M, Ojcius DM, Hacker G: Host-cell survival and death during Chlamydia infection. Curr Immunol Rev 2007, 3(1):31-40.
12. Omsland A, Sager J, Nair V, Sturdevant DE, Hackstadt T: Developmental stage-specific metabolic and transcriptional activity of Chlamydia trachomatis in an axenic medium. Proc Natl Acad Sci U S A 2012, 109(48):19781-19785.
13. Haider S, Wagner M, Schmid MC, Sixt BS, Christian JG, Hacker G, Pichler P, Mechtler K, Muller A, Baranyi C, Toenshoff ER, Montanaro J, Horn M: Raman microspectroscopy reveals long-term extracellular activity of Chlamydiae. Mol Microbiol 2010, 77(3):687-700.
14. Hybiske K, Stephens RS: Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A 2007, 104(27):11430-11435.
15. Kim M, Ashida H, Ogawa M, Yoshikawa Y, Mimuro H, Sasakawa C: Bacterial interactions with the host epithelium. Cell Host Microbe 2010, 8(1):20-35.
16. Birkelund S, Johnsen H, Christiansen G: Chlamydia trachomatis serovar L2 induces protein tyrosine phosphorylation during uptake by HeLa cells. Infect Immun 1994, 62(11):4900-4908.
17. Fawaz FS, van Ooij C, Homola E, Mutka SC, Engel JN: Infection with Chlamydia trachomatis alters the tyrosine phosphorylation and/or localization of several host cell proteins including cortactin. Infect Immun 1997, 65(12):5301-5308.
18. Kumar Y, Valdivia RH: Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 2008, 4(2):159-169.
19. Elwell CA, Ceesay A, Kim JH, Kalman D, Engel JN: RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog 2008, 4(3):e1000021.
20. Kim JH, Jiang S, Elwell CA, Engel JN: Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection. PLoS Pathog 2011, 7(10):e1002285.
21. Nicholson RI, Gee JM, Harper ME: EGFR and cancer prognosis. Eur J Cancer 2001, 37(Suppl 4):S9-15.
22. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Narvanen A, Pukkala E, Thoresen S, Youngman L, Paavonen J: Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. J Am Med Assoc 2001, 285(1):47-51.
23. Idahl A, Lundin E, Jurstrand M, Kumlin U, Elgh F, Ohlson N, Ottander U: Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors. Infect Dis Obstet Gynecol 2011, 2011:824627.
24. Fischer N: Chlamydia trachomatis infection in cervical intraepithelial neoplasia and invasive carcinoma. Eur J Gynaecol Oncol 2002, 23(3):247-250.
25. Molleken K, Becker E, Hegemann JH: The Chlamydia pneumoniae invasin protein Pmp21 recruits the EGF receptor for host cell entry. PLoS Pathog 2013, 9(4):e1003325.
26. Zhang J, Li H, Wang J, Dong Z, Mian S, Yu FS: Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells. Invest Ophthalmol Vis Sci 2004, 45(8):2569-2576.
27. Su H, McClarty G, Dong F, Hatch GM, Pan ZK, Zhong G: Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J Biol Chem 2004, 279(10):9409-9416.
28. Gurumurthy RK, Maurer AP, Machuy N, Hess S, Pleissner KP, Schuchhardt J, Rudel T, Meyer TF: A loss-of-function screen reveals Ras- and Raf-independent MEK-ERK signaling during Chlamydia trachomatis infection. Sci Signal 2010, 3(113):ra21.
29. Verbeke P, Welter-Stahl L, Ying S, Hansen J, Hacker G, Darville T, Ojcius DM: Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with host-cell survival. PLoS Pathog 2006, 2(5):e45.
30. Swanson KV, Griffiss JM, Edwards VL, Stein DC, Song W: Neisseria gonorrhoeae-induced transactivation of EGFR enhances gonococcal invasion. Cell Microbiol 2011, 13(7):1078-1090.
31. Li S, Wang Q, Wang Y, Chen X, Wang Z: PLC-gamma1 and Rac1 coregulate EGF-induced cytoskeleton remodeling and cell migration. Mol Endocrinol 2009, 23(6):901-913.
32. Majeed M, Gustafsson M, Kihlstrom E, Stendahl O: Roles of Ca2+ and F-actin in intracellular aggregation of Chlamydia trachomatis in eucaryotic cells. Infect Immun 1993, 61(4):1406-1414.
33. Boleti H, Benmerah A, Ojcius DM, Cerf-Bensussan N, Dautry-Varsat A: Chlamydia infection of epithelial cells expressing dynamin and Eps15 mutants: clathrin-independent entry into cells and dynamin-dependent productive growth. J Cell Sci 1999, 112(Pt 10):1487-1496.
34. den Hartigh JC, van Bergen en Henegouwen PM, Verkleij AJ, Boonstra J: The EGF receptor is an actin-binding protein. J Cell Biol 1992, 119(2):349-355.
35. Chung I, Akita R, Vandlen R, Toomre D, Schlessinger J, Mellman I: Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 2010, 464(7289):783-787.
36. Lo HW, Hung MC: Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer 2006, 94(2):184-188.
37. Hung LY, Tseng JT, Lee YC, Xia W, Wang YN, Wu ML, Chuang YH, Lai CH, Chang WC: Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Res 2008, 36(13):4337-4351.
38. Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino G, Lin PS: ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene 2003, 22(37):5855-5865.
39. Myllynen L, Rieckmann T, Dahm-Daphi J, Kasten-Pisula U, Petersen C, Dikomey E, Kriegs M: In tumor cells regulation of DNA double strand break repair through EGF receptor involves both NHEJ and HR and is independent of p53 and K-Ras status. Radiother Oncol 2011, 101(1):147-151.
40. Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H, Peyton M, Juroske D, Huang Y, Stuart Salmon J, Kim YH, Pollack JR, Yanagisawa K, Gazdar A, Minna JD, Kurie JM, Carbone DP: Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res 2005, 65(1):226-235.
41. Boehrer S, Galluzzi L, Lainey E, Bouteloup C, Tailler M, Harper F, Pierron G, Ades L, Thepot S, Sebert M, Gardin C, de Botton S, Fenaux P, Kroemer G: Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia. Cell Cycle 2011, 10(18):3168-3175.
42. Murray A, Ward ME: Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: the role of calmodulin. J Gen Microbiol 1984, 130(1):193-201.
43. Bryant JA, Finn RS, Slamon DJ, Cloughesy TF, Charles AC: EGF activates intracellular and intercellular calcium signaling by distinct pathways in tumor cells. Cancer Biol Ther 2004, 3(12):1243-1249.
44. TranVan Nhieu G, Clair C, Grompone G, Sansonetti P: Calcium signalling during cell interactions with bacterial pathogens. Biol Cell 2004, 96(1):93-101.
45. Stoorvogel W, Kerstens S, Fritzsche I, den Hartigh JC, Oud R, van der Heyden MA, Voortman J, van Bergen en Henegouwen PM: Sorting of ligand-activated epidermal growth factor receptor to lysosomes requires its actin-binding domain. J Biol Chem 2004, 279(12):11562-11569.
46. Yi KS, Chung JH, Lee YH, Chung HG, Kim IJ, Suh BC, Kim E, Cocco L, Ryu SH, Suh PG: Inhibition of the EGF-induced activation of phospholipase C-gamma1 by a single chain antibody fragment. Oncogene 2001, 20(55):7954-7964.
47. Jaskolski F, Mulle C, Manzoni OJ: An automated method to quantify and visualize colocalized fluorescent signals. J Neurosci Methods 2005, 146(1):42-49.
48. Bolte S, Cordelieres FP: A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006, 224(Pt 3):213-232.
49. Schlessinger J, Ullrich A: Growth factor signaling by receptor tyrosine kinases. Neuron 1992, 9(3):383-391.
50. Faherty CS, Maurelli AT: Staying alive: bacterial inhibition of apoptosis during infection. Trends Microbiol 2008, 16(4):173-180.
51. Grieshaber SS, Grieshaber NA, Miller N, Hackstadt T: Chlamydia trachomatis causes centrosomal defects resulting in chromosomal segregation abnormalities. Traffic 2006, 7(8):940-949.
52. Johnson KA, Tan M, Sutterlin C: Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway. Cell Microbiol 2009, 11(7):1064-1073.
53. Vanderheyden V, Devogelaere B, Missiaen L, De Smedt H, Bultynck G, Parys JB: Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation. Biochim Biophys Acta 2009, 1793(6):959-970.
54. Majeed M, Krause KH, Clark RA, Kihlstrom E, Stendahl O: Localization of intracellular Ca2+ stores in HeLa cells during infection with Chlamydia trachomatis.J Cell Sci 1999, 112(Pt 1):35-44.
55. Tang J, Gross DJ: Regulated EGF receptor binding to F-actin modulates receptor phosphorylation. Biochem Biophys Res Commun 2003, 312(4):930-936.
56. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ, Carabeo RA, Hackstadt T: A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A 2004, 101(27):10166-10171.
57. Clifton DR, Dooley CA, Grieshaber SS, Carabeo RA, Fields KA, Hackstadt T: Tyrosine phosphorylation of the chlamydial effector protein Tarp is species specific and not required for recruitment of actin. Infect Immun 2005, 73(7):3860-3868.
58. Balana ME, Niedergang F, Subtil A, Alcover A, Chavrier P, Dautry-Varsat A: ARF6 GTPase controls bacterial invasion by actin remodelling. J Cell Sci 2005, 118(Pt 10):2201-2210.
59. Carabeo RA, Grieshaber SS, Fischer E, Hackstadt T: Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect Immun 2002, 70(7):3793-3803.
60. Ling YH, Li T, Perez-Soler R, Haigentz M Jr: Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib. Cancer Chemother Pharmacol 2009, 64(3):539-548.
61. Bjorkelund H, Gedda L, Andersson K: Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular context. PLoS One 2011, 6(1):e16536.
62. Gan HK, Walker F, Burgess AW, Rigopoulos A, Scott AM, Johns TG: The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. J Biol Chem 2007, 282(5):2840-2850.
63. Rodriguez-Boulan E, Kreitzer G, Musch A: Organization of vesicular trafficking in epithelia. Nat Rev Mol Cell Biol 2005, 6(3):233-247.
64. Lui VW, Thomas SM, Zhang Q, Wentzel AL, Siegfried JM, Li JY, Grandis JR: Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. Oncogene 2003, 22(40):6183-6193.